These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2272046)

  • 1. Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930.
    Gamse R
    Cancer Treat Rev; 1990 Sep; 17(2-3):301-5. PubMed ID: 2272046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
    Kidgell AE; Butcher ME; Brown GW
    Cancer Treat Rev; 1990 Sep; 17(2-3):311-7. PubMed ID: 2176933
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patients.
    Havsteen H; Andersen LJ; Kjaer M; Dalmark M
    Anticancer Drugs; 1994 Aug; 5(4):410-8. PubMed ID: 7949244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Morrow GR; Hickok JT; Rosenthal SN
    Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases].
    Buiuc AI; Găleşanu MR
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetron.
    Seynaeve C; Verweij J; de Mulder PH
    Anticancer Drugs; 1991 Aug; 2(4):343-55. PubMed ID: 1665723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy.
    Hachimi-Idrissi S; De Schepper J; Maurus R; Otten J
    Eur J Cancer; 1993; 29A(6):854-6. PubMed ID: 8484976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
    Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
    Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
    Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
    Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
    Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R
    Drugs; 1992; 43 Suppl 3():6-10. PubMed ID: 1380432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.